Emily Pimblett
Fortuna: 224 767 $ al 31/07/2026
Fortuna: 224 767 $ al 31/07/2026
Emily Pimblett worked as Controller at Avvo, Inc. from 2017 to 2019.
Ms. Pimblett worked as Controller at DomainTools LLC from 2019 to 2021.
Ms. Pimblett worked as Chief Accounting Officer at Climb Bio, Inc. from 2023 to 2025.
Ms. Pimblett completed undergraduate and graduate degrees at the University of Washington.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CLIMB BIO, INC. 0,03 % | 20/06/2025 | 18.888 ( 0,03 % ) | 224 767 $ | 31/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Comptroller/Controller/Auditor | 01/03/2021 |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Comptroller/Controller/Auditor | 01/03/2019 |
| CLIMB BIO, INC. | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Commercial Services |
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Technology Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.